Intrathecal baclofen for motor disorders

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 1995 English Publisher:WileyJournal:Movement Disorders, volume 10, pages 675-677 (issn: 0885-3185, eissn: 1531-8257,

Copyright policy )

Authors: R D, Penn; J M, Gianino; M M, York;

doi: 10.1002/mds.870100524

pmid: 8552124

Intrathecal baclofen for motor disorders

- Summary
- Subjects
- Metrics

Abstract

AbstractTo test the efficacy of intrathecal baclofen in various movement disorders, 18 patients with dystonia, head trauma, cerebral palsy, rigidity, or painful spasms underwent a trial of intrathecal baclofen. Ten went on to permanent implantation with an infusion pump to provide long‐term treatment. Patients with a component of spasticity, painful spasms, or focal dystonias did best, and no response was seen in patients with rigidity due to anoxic encephalopathy. A videotape of responses is provided.

Related Organizations

Presbyterian St. Luke's Medical Center
United States
Rush University Medical Center
United States

Keywords

Adult, Male, Baclofen, Movement Disorders, Adolescent, Muscle Relaxants, Central, Cerebral Palsy, Videotape Recording, Middle Aged, Muscle Rigidity, Dystonia, Treatment Outcome, Muscle Spasticity, Craniocerebral Trauma, Humans, Female, Injections, Spinal

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	70
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%